MSLP - MusclePharm Corporation

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 510.9M
Enterprise Value 330.54M
Trailing P/E N/A
Forward P/E 1-1.95
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)0.11
Price/Book (mrq)N/A
Enterprise Value/Revenue 30.30
Enterprise Value/EBITDA 6-63.38

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Mar 31, 2018


Profit Margin -9.86%
Operating Margin (ttm)-1.76%

Management Effectiveness

Return on Assets (ttm)-3.48%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)102.69M
Revenue Per Share (ttm)7.29
Quarterly Revenue Growth (yoy)2.10%
Gross Profit (ttm)30.45M
EBITDA -481.9k
Net Income Avi to Common (ttm)-10.13M
Diluted EPS (ttm)-0.72
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)5.11M
Total Cash Per Share (mrq)0.35
Total Debt (mrq)24.7M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.01
Book Value Per Share (mrq)-0.99

Cash Flow Statement

Operating Cash Flow (ttm)-4.32M
Levered Free Cash Flow (ttm)1.49M

Trading Information

Stock Price History

Beta 2.93
52-Week Change 3-65.00%
S&P500 52-Week Change 313.49%
52 Week High 32.05
52 Week Low 30.00
50-Day Moving Average 30.72
200-Day Moving Average 30.77

Share Statistics

Avg Vol (3 month) 37.19k
Avg Vol (10 day) 32.39k
Shares Outstanding 514.73M
Float 8.74M
% Held by Insiders 132.20%
% Held by Institutions 19.14%
Shares Short 3N/A
Short Ratio 3N/A
Short % of Float 3N/A
Shares Short (prior month) 3N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/850
Last Split Date 3Nov 26, 2012